Accelerating path to clinic through an end-to-end solution focused on supply chain, regulatory, and a robust manufacturing process for viral vectors


Enhancing the path to clinic with an end-to-end solution that addresses supply chain, regulatory, and robust manufacturing processes for viral vectors.

Learn more about a true end-to-end offering for AAV and LV vector manufacturing